["{\n\"step_by_step_thinking\": \"Since Tocilizumab is Actemra, we need to look for information about Actemra's mechanism of action. From the provided documents, we can see that IL-6 plays a role in various disease states and its receptor (IL-6R) is expressed on blood lymphocytes. Based on this information, it seems likely that Actemra (Tocilizumab) would be an IL-6 antagonist or blocker. Therefore, the answer should be...\",\n\"answer_choice\": \"A\"\n}"]